FTC: Promoter of $23,000 COVID-19 'Treatment' Plan Barred From Making Bogus Health Claims
June 15, 2021
June 15, 2021
WASHINGTON, June 15 -- The Federal Trade Commission issued the following news release:
The medical director of California-based Golden Sunrise Nutraceutical, Inc., agreed to settle Federal Trade Commission charges that he took part in deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19. Dr. Stephen Meis will be barred from making similar unsupported health claims in the future and will pay $103,420 to provide refunds to defrauded consume . . .
The medical director of California-based Golden Sunrise Nutraceutical, Inc., agreed to settle Federal Trade Commission charges that he took part in deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19. Dr. Stephen Meis will be barred from making similar unsupported health claims in the future and will pay $103,420 to provide refunds to defrauded consume . . .